JP2013523694A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523694A5 JP2013523694A5 JP2013501854A JP2013501854A JP2013523694A5 JP 2013523694 A5 JP2013523694 A5 JP 2013523694A5 JP 2013501854 A JP2013501854 A JP 2013501854A JP 2013501854 A JP2013501854 A JP 2013501854A JP 2013523694 A5 JP2013523694 A5 JP 2013523694A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- composition
- composition according
- amount
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 21
- 239000002904 solvent Substances 0.000 claims 5
- 239000003589 local anesthetic agent Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 150000004671 saturated fatty acids Chemical class 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 2
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 claims 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 2
- 239000005642 Oleic acid Substances 0.000 claims 2
- 206010000210 abortion Diseases 0.000 claims 2
- 231100000176 abortion Toxicity 0.000 claims 2
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 claims 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 2
- 150000004668 long chain fatty acids Chemical class 0.000 claims 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 2
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 claims 2
- 229960003656 ricinoleic acid Drugs 0.000 claims 2
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 claims 2
- 229960001549 ropivacaine Drugs 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 235000003441 saturated fatty acids Nutrition 0.000 claims 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims 1
- 206010000234 Abortion spontaneous Diseases 0.000 claims 1
- 235000021314 Palmitic acid Nutrition 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims 1
- 229960003150 bupivacaine Drugs 0.000 claims 1
- 239000004359 castor oil Substances 0.000 claims 1
- 235000019438 castor oil Nutrition 0.000 claims 1
- 210000003679 cervix uteri Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000004720 fertilization Effects 0.000 claims 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229960004288 levobupivacaine Drugs 0.000 claims 1
- LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 claims 1
- 229960005015 local anesthetics Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 239000012074 organic phase Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229950008882 polysorbate Drugs 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 208000000995 spontaneous abortion Diseases 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1050322 | 2010-04-01 | ||
| SE1050322-5 | 2010-04-01 | ||
| US32542510P | 2010-04-19 | 2010-04-19 | |
| US61/325,425 | 2010-04-19 | ||
| PCT/EP2011/055025 WO2011121082A1 (en) | 2010-04-01 | 2011-03-31 | Bioadhesive compositions of local anaesthetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013523694A JP2013523694A (ja) | 2013-06-17 |
| JP2013523694A5 true JP2013523694A5 (enExample) | 2014-05-22 |
Family
ID=44278867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501854A Pending JP2013523694A (ja) | 2010-04-01 | 2011-03-31 | 局所麻酔薬の生体接着性組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20130079371A1 (enExample) |
| EP (1) | EP2552409A1 (enExample) |
| JP (1) | JP2013523694A (enExample) |
| KR (1) | KR20130080435A (enExample) |
| CN (1) | CN102869344A (enExample) |
| AU (1) | AU2011234415C1 (enExample) |
| BR (1) | BR112012024885A2 (enExample) |
| CA (1) | CA2794280A1 (enExample) |
| CL (1) | CL2012002705A1 (enExample) |
| EA (1) | EA201290790A1 (enExample) |
| IL (1) | IL222225A0 (enExample) |
| MX (1) | MX2012011261A (enExample) |
| NZ (1) | NZ602540A (enExample) |
| PH (1) | PH12012501887A1 (enExample) |
| SG (1) | SG184072A1 (enExample) |
| WO (1) | WO2011121082A1 (enExample) |
| ZA (1) | ZA201206989B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9308181B2 (en) | 2006-03-06 | 2016-04-12 | Nuvo Research Inc. | Topical formulations, systems and methods |
| US9642912B2 (en) | 2006-03-06 | 2017-05-09 | Crescita Therapeutics Inc. | Topical formulations for treating skin conditions |
| WO2010033726A2 (en) | 2008-09-17 | 2010-03-25 | The Brigham And Women's Hospital, Inc. | Drug delivery composition comprising a self-assembled gelator |
| WO2012040623A2 (en) | 2010-09-24 | 2012-03-29 | The Brigham And Women's Hospital, Inc. | Nanostructured gels capable of controlled release of encapsulated agents |
| KR101768843B1 (ko) * | 2013-02-28 | 2017-08-17 | 미라 파마 코포레이션 | 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물 |
| US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
| GB201317718D0 (en) | 2013-10-07 | 2013-11-20 | Buzzz Pharmaceuticals Ltd | Novel formulation |
| WO2016152186A1 (ja) | 2015-03-25 | 2016-09-29 | テルモ株式会社 | ゲル状局所麻酔剤およびそれを用いたゲル状局所麻酔製剤 |
| AU2016352007B2 (en) | 2015-11-12 | 2022-03-17 | Terumo Kabushiki Kaisha | Sustained-release topically administered agent |
| WO2018144991A1 (en) | 2017-02-03 | 2018-08-09 | The Brigham And Women's Hospital, Inc. | Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof |
| CA3061480A1 (en) * | 2017-05-08 | 2018-11-15 | Alivio Therapeutics, Inc. | Formulation of nanostructured gels for increased agent loading and adhesion |
| US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
| JP7046396B2 (ja) | 2017-12-06 | 2022-04-04 | 湖州惠中濟世生物科技有限公司 | 注射可能な長時間作用性局所麻酔薬半固形製剤 |
| US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
| CN113825495A (zh) | 2018-10-11 | 2021-12-21 | 阿利维奥治疗学股份有限公司 | 用于智能释放的不可注射水凝胶调配物 |
| JP2024505227A (ja) * | 2021-01-29 | 2024-02-05 | インシツ バイオロジクス、インク． | 疼痛の持続的治療のための組成物および方法 |
| CN118697692B (zh) * | 2024-06-27 | 2024-11-26 | 山东中医药大学附属医院 | 一种防苦麻醉胶浆剂、方法及应用 |
| CN119587525B (zh) * | 2024-11-07 | 2025-09-05 | 海南三帝制药有限公司 | 一种二甲卡因复合制剂及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
| AU685262B2 (en) * | 1994-03-30 | 1998-01-15 | Gs Development Ab | Use of fatty acid esters as bioadhesive substances |
| SE9601421D0 (sv) | 1996-04-12 | 1996-04-12 | Astra Ab | New composition |
| JP2001503035A (ja) * | 1996-10-14 | 2001-03-06 | 興和株式会社 | 外用局所麻酔剤 |
| US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| US20060115522A1 (en) * | 2003-02-17 | 2006-06-01 | Cipla Ltd | Pharmaceutical composition |
| US20050084508A1 (en) | 2003-07-22 | 2005-04-21 | Vancaillie Thierry G. | Topical anesthesia formulation for bodily cavities |
| PL1845942T3 (pl) * | 2005-01-14 | 2014-07-31 | Camurus Ab | Preparaty analogu GnRH |
| JP4931369B2 (ja) | 2005-05-31 | 2012-05-16 | ポーラ化成工業株式会社 | リポソームおよびそれを含む処置用の組成物 |
| CN101374554A (zh) * | 2005-09-27 | 2009-02-25 | 埃弗拉特生物聚合物有限公司 | 胶凝疏水性可注射聚合物组合物 |
| GB0524958D0 (en) * | 2005-12-07 | 2006-01-18 | Pharmakodex Ltd | Transdermal administration of active agents |
| US20070280972A1 (en) * | 2006-04-25 | 2007-12-06 | Zars, Inc. | Adhesive solid gel-forming formulations for dermal drug delivery |
| US20070269386A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
| JP5181320B2 (ja) * | 2006-10-18 | 2013-04-10 | ニチバン株式会社 | 皮膚刺激の少ない経皮吸収型製剤 |
| US9918934B2 (en) | 2006-12-12 | 2018-03-20 | Edgar Joel Acosta-Zara | Linker-based lecithin microemulsion delivery vehicles |
| US20090247494A1 (en) | 2008-04-01 | 2009-10-01 | Phillip Mark Kofsky | Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders |
-
2011
- 2011-03-31 MX MX2012011261A patent/MX2012011261A/es not_active Application Discontinuation
- 2011-03-31 CA CA2794280A patent/CA2794280A1/en not_active Abandoned
- 2011-03-31 SG SG2012068250A patent/SG184072A1/en unknown
- 2011-03-31 KR KR1020127028642A patent/KR20130080435A/ko not_active Withdrawn
- 2011-03-31 EA EA201290790A patent/EA201290790A1/ru unknown
- 2011-03-31 CN CN2011800166567A patent/CN102869344A/zh active Pending
- 2011-03-31 WO PCT/EP2011/055025 patent/WO2011121082A1/en not_active Ceased
- 2011-03-31 BR BR112012024885A patent/BR112012024885A2/pt not_active IP Right Cessation
- 2011-03-31 NZ NZ602540A patent/NZ602540A/en not_active IP Right Cessation
- 2011-03-31 US US13/638,519 patent/US20130079371A1/en not_active Abandoned
- 2011-03-31 AU AU2011234415A patent/AU2011234415C1/en not_active Ceased
- 2011-03-31 EP EP11711566A patent/EP2552409A1/en not_active Withdrawn
- 2011-03-31 JP JP2013501854A patent/JP2013523694A/ja active Pending
- 2011-03-31 PH PH1/2012/501887A patent/PH12012501887A1/en unknown
-
2012
- 2012-09-18 ZA ZA2012/06989A patent/ZA201206989B/en unknown
- 2012-09-27 CL CL2012002705A patent/CL2012002705A1/es unknown
- 2012-09-27 IL IL222225A patent/IL222225A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ602540A (en) | Bioadhesive compositions of local anaesthetics | |
| CN104968368B (zh) | 固溶体组合物及其在剧痛中的用途 | |
| AU2014363599B2 (en) | Orally disintegrating solid dosage unit containing an estetrol component | |
| JP2013523693A5 (enExample) | ||
| JP5972862B2 (ja) | 熱ゲル化麻酔組成物 | |
| FI3360575T3 (fi) | Ihon kautta annosteltavat farmaseuttiset koostumukset, jotka käsittävät vaikuttavia aineita | |
| JP6989489B2 (ja) | Ｎｓａｉｄのための固溶体組成物 | |
| JP2007523049A5 (enExample) | ||
| JP2013522230A5 (enExample) | ||
| HRP20171319T1 (hr) | Monolitni intravaginalni prsten koji sadrži progesteron i metode njegove izrade i uporabe | |
| NZ596946A (en) | Solid compositions comprising 5-aminolevulinic acid | |
| JP2015504924A5 (enExample) | ||
| JP2013529645A (ja) | ナイアシン模倣体、およびその使用方法 | |
| JP2015522649A5 (enExample) | ||
| JP2012505867A5 (enExample) | ||
| BR112012017476A2 (pt) | composto, composição, método para preparar uma composição, uso de um composto, e, métodos para tratar doenças, para inibir um alérgico peptidase do ácaro da poeira, para exterminar ácaros, para controlar uma população de ácaros | |
| US20140066481A1 (en) | Water-Free Pharmaceutical Compositions Suitable for Local Anaesthetics | |
| JP2013514979A5 (enExample) | ||
| JP2024059876A5 (enExample) | ||
| JP2020182497A5 (enExample) | ||
| GB2600270A (en) | Bioactive implants for drug delivery | |
| JP5642658B2 (ja) | 非水性貼付剤 | |
| CA2659344C (en) | Treatment and prevention of excessive scarring | |
| WO2017025989A1 (en) | Method of wound healing | |
| JP2019514977A5 (enExample) |